Insights On Trial Design

  1. Key Risk Areas that Can Derail Clinical Trials with Ocular Endpoints 1/15/2025

    By embracing point-of-need models and strategic collaborations, sponsors and CROs can streamline ophthalmic trials and maximize ROI while advancing sight-saving therapies.

  2. Think U.S.A.: The Operations Behind Your Clinical Trials 1/22/2025

    Ready to think differently about early-phase clinical development? Check out the spotlight on our U.S. clinical facilities and the incredible teams behind them.

  3. Five Predictions For Clinical Research In 2025 2/19/2025

    In 2025, AI-powered adaptive protocols will redefine study design, shifting the industry from rigid, pre-planned models to flexible, real-world-optimized trials.

  4. RTSM And IRT Solutions For Clinical Trials 12/10/2025

    Global leader in RTSM/IRT, helping sponsors and CROs speed study start-up, optimize supply, and manage complex trials with confidence.

  5. Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays 9/25/2025

    Receptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.

  6. What Clinical Trial Decision Makers Are Prioritizing In 2025 5/7/2025

    In 2025, clinical trial operations are undergoing a transformative shift driven by the need for speed, cost-efficiency, and patient-centered approaches.

  7. Improving The eCOA Experience 1/25/2026

    Discover how template-driven builds and reuse can slash eCOA timelines by 50% while solving the licensing and translation hurdles that delay First Patient In.

  8. Why Do Clinical Trials Cost So Much? Looking Beyond The Obvious 6/29/2026

    The true cost of research goes beyond budgets to design, data, and execution inefficiencies. Streamlining processes and early decisions reduces delays, controls costs, and improves study quality.

  9. Solutions To The Challenges Of Oncology Trials 5/6/2025

    This significant Phase III trial, one of the largest global studies in head and neck cancer, faced considerable challenges including enrollment delays and an intricate study design.

  10. Eligibility Criteria For Successful Retinal Study Delivery 1/14/2026

    Clear eligibility criteria drive retinal trial success. Explore how strategic design improves recruitment, safeguards data integrity, and meets compliance for studies on complex ocular conditions.